General Information of the Compound
| Compound ID |
CP0970240
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4'-((4-(9-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yloxy)nonyl)piperazin-1-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methylbiphenyl-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C56H71N7O8
|
||||||||||||||||||
| Molecular Weight |
970.225
|
||||||||||||||||||
| Canonical SMILES |
CCN(c1cc(-c2ccc(CN3CCN(CCCCCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C56H71N7O8/c1-5-62(43-22-30-70-31-23-43)48-34-42(33-45(39(48)4)52(65)57-35-46-37(2)32-38(3)58-53(46)66)41-18-16-40(17-19-41)36-61-27-25-60(26-28-61)24-11-9-7-6-8-10-12-29-71-49-15-13-14-44-51(49)56(69)63(55(44)68)47-20-21-50(64)59-54(47)67/h13-19,32-34,43,47H,5-12,20-31,35-36H2,1-4H3,(H,57,65)(H,58,66)(H,59,64,67)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PIAVNVUXSGPKDT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound